Dr. Reddy's Laboratories Ltd. ADS (RDY) Financials
Post# of 250602
Posted On: 11/18/2014 7:18:40 AM
Dr. Reddy's Laboratories Ltd. ADS (RDY) Financials Nov 17, 2014, 4:01 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Dr. Reddy's Laboratories Ltd. ADS
Fiscal year is April-March. All values INR millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 70.31B 74.69B 96.74B 116.27B 132.17B
Cost of Goods Sold (COGS) incl. D&A 43.48B 36.41B 45.92B 58.25B 59.7B
COGS excluding D&A 39.35B 32.26B 40.7B 52.7B 52.6B
Depreciation & Amortization Expense 4.13B 4.15B 5.21B 5.55B 7.11B
Depreciation 2.65B 2.96B 3.63B 3.86B 4.81B
Amortization of Intangibles 1.48B 1.19B 1.59B 1.69B 2.3B
Gross Income 26.83B 38.29B 50.82B 58.01B 72.47B
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 14.76B 26.77B 32.29B 38.69B 48.35B
Research & Development 3.73B 4.72B 5.53B 7.31B 11.97B
Other SG&A 11.03B 22.05B 26.76B 31.39B 36.38B
Other Operating Expense 1.81B 0 0 (168M) 0
Unusual Expense 4.58B 80M 1.05B (424M) (912M)
EBIT after Unusual Expense (4.58B) (80M) (1.05B) 424M 912M
Non Operating Income/Expense 589M 1.19B 1.63B 1.78B 1.59B
Non-Operating Interest Income 249M 105M 377M 900M 1.09B
Equity in Affiliates (Pretax) 0 - - - -
Interest Expense 312M 289M 1.07B 1.02B 1.27B
Gross Interest Expense 312M 289M 1.07B 1.02B 1.27B
Interest Capitalized 0 0 0 0 0
Pretax Income 6.21B 12.44B 18.41B 21.57B 26.43B
Income Tax 2.69B 1.4B 4.2B 4.9B 5.09B
Income Tax - Current Domestic 2.57B 2.25B 3.62B 4.31B 5.09B
Income Tax - Current Foreign 687M 673M 733M 2.14B 1.47B
Income Tax - Deferred Domestic (154M) (698M) 424M 257M 294M
Income Tax - Deferred Foreign (406M) (825M) (574M) (1.81B) (1.76B)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 3M 54M 104M 174M
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income 3.52B 11.04B 14.26B 16.78B 21.51B
Minority Interest Expense 0 0 0 (1M) (3M)
Net Income 3.52B 11.04B 14.26B 16.78B 21.52B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 - - - -
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 3.52B 11.04B 14.26B 16.78B 21.52B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 3.52B 11.04B 14.26B 16.78B 21.52B
EPS (Basic) 20.83 65.28 84.16 98.82 126.52
Basic Shares Outstanding 168.71M 169.13M 169.47M 169.78M 170.04M
EPS (Diluted) 20.69 64.95 83.81 98.44 126.04
Diluted Shares Outstanding 169.86M 169.97M 170.18M 170.43M 170.7M
EBITDA 14.4B 15.66B 23.74B 25.04B 31.23B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Dr. Reddy's Laboratories Ltd. ADS
Fiscal year is April-March. All values INR millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 70.31B 74.69B 96.74B 116.27B 132.17B
Cost of Goods Sold (COGS) incl. D&A 43.48B 36.41B 45.92B 58.25B 59.7B
COGS excluding D&A 39.35B 32.26B 40.7B 52.7B 52.6B
Depreciation & Amortization Expense 4.13B 4.15B 5.21B 5.55B 7.11B
Depreciation 2.65B 2.96B 3.63B 3.86B 4.81B
Amortization of Intangibles 1.48B 1.19B 1.59B 1.69B 2.3B
Gross Income 26.83B 38.29B 50.82B 58.01B 72.47B
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 14.76B 26.77B 32.29B 38.69B 48.35B
Research & Development 3.73B 4.72B 5.53B 7.31B 11.97B
Other SG&A 11.03B 22.05B 26.76B 31.39B 36.38B
Other Operating Expense 1.81B 0 0 (168M) 0
Unusual Expense 4.58B 80M 1.05B (424M) (912M)
EBIT after Unusual Expense (4.58B) (80M) (1.05B) 424M 912M
Non Operating Income/Expense 589M 1.19B 1.63B 1.78B 1.59B
Non-Operating Interest Income 249M 105M 377M 900M 1.09B
Equity in Affiliates (Pretax) 0 - - - -
Interest Expense 312M 289M 1.07B 1.02B 1.27B
Gross Interest Expense 312M 289M 1.07B 1.02B 1.27B
Interest Capitalized 0 0 0 0 0
Pretax Income 6.21B 12.44B 18.41B 21.57B 26.43B
Income Tax 2.69B 1.4B 4.2B 4.9B 5.09B
Income Tax - Current Domestic 2.57B 2.25B 3.62B 4.31B 5.09B
Income Tax - Current Foreign 687M 673M 733M 2.14B 1.47B
Income Tax - Deferred Domestic (154M) (698M) 424M 257M 294M
Income Tax - Deferred Foreign (406M) (825M) (574M) (1.81B) (1.76B)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 3M 54M 104M 174M
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income 3.52B 11.04B 14.26B 16.78B 21.51B
Minority Interest Expense 0 0 0 (1M) (3M)
Net Income 3.52B 11.04B 14.26B 16.78B 21.52B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 - - - -
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 3.52B 11.04B 14.26B 16.78B 21.52B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 3.52B 11.04B 14.26B 16.78B 21.52B
EPS (Basic) 20.83 65.28 84.16 98.82 126.52
Basic Shares Outstanding 168.71M 169.13M 169.47M 169.78M 170.04M
EPS (Diluted) 20.69 64.95 83.81 98.44 126.04
Diluted Shares Outstanding 169.86M 169.97M 170.18M 170.43M 170.7M
EBITDA 14.4B 15.66B 23.74B 25.04B 31.23B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼